Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-08-24

FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Zidovudine from Aurobindo Pharma Limited, authorizing changes related to the generic Zidovudine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zidovudine (Zidovudine)

Snippet

SUPPL AP for ZIDOVUDINE (ZIDOVUDINE)